CFTR and cystic fibrosis: These nanoparticles have been used in a phase I/II clinical trials to deliver the cystic fibrosis transmembrane regulator (CFTR) gene to cystic fibrosis (CF) patients [19] and are also being developed for treatment of genetic brain diseases [20].